Reference : Distinction entre patients bons synthetiseurs et bons absorbeurs pour optimiser le tr...
Scientific journals : Article
Human health sciences : Pharmacy, pharmacology & toxicology
Human health sciences : Endocrinology, metabolism & nutrition
http://hdl.handle.net/2268/11065
Distinction entre patients bons synthetiseurs et bons absorbeurs pour optimiser le traitement hypo- cholesterolemiant.
French
[en] Distinction between good synthesizer and good absorber patients to optimize cholesterol-lowering therapy
Radermecker, Régis mailto [Centre Hospitalier Universitaire de Liège - CHU > > Diabétologie,nutrition, maladies métaboliques >]
Scheen, André mailto [Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale >]
2006
Revue Médicale Suisse
2
76
1910-5
Yes (verified by ORBi)
International
1660-9379
Switzerland
[en] Cholesterol/pharmacokinetics ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Hypercholesterolemia/prevention & control ; Intestinal Absorption ; Phytosterols/pharmacokinetics
[en] The inhibition of cholesterol synthesis by a statin enhances intestinal absorption of both cholesterol and various phytosterols. The atherogenic role of phytosterols, well proven in hypersitosterolemia, is now suspected in patients with premature coronary artery disease. The cholestanol/cholesterol ratio can be used as a marker of intestinal cholesterol absorption. Individuals with elevated ratio ("high absorbers") have less favourable cholesterol-lowering response and cardiovascular protection with statin therapy as compared to individuals with low ratio ("high synthesizers"). They may benefit of an adjunct therapy with phytostanols or ezetimibe, both being capable to reduce plasma concentrations of cholesterol and of phytosterols.
Researchers ; Professionals ; Students
http://hdl.handle.net/2268/11065
http://www.revmed.ch

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Distinction entre patients bons synthétiseurs et bons absorbeurs pour optimiser le traitement hypocholestérolémiant.pdfNo commentaryPublisher postprint102.12 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.